STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?
A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart health.
خواندن متن کامل در استتنیوزبه زبان اصلی، در سایت ناشر باز میشودمتن اصلی (انگلیسی)
STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?
A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart health.